Hudson Vegas Investment SPV, LLC
Known title: 10% OwnerCIK: 0001900112
Associated companies
Transaction History
| PIII | ▼ Sell | Other | 100,000 | — | 8/13/2026 | View on chart |
| PIII | ▼ Sell | Other | 100,000 | — | 8/13/2026 | View on chart |
| PIII | ▼ Sell | Open Market | 1,041 | $14K | 8/10/2026 | View on chart |
| PIII | ▼ Sell | Open Market | 19,074 | $306K | 8/10/2026 | View on chart |
| PIII | ▼ Sell | Open Market | 29,885 | $504K | 8/10/2026 | View on chart |
| PIII | ▼ Sell | Other | 50,000 | — | 6/10/2026 | View on chart |
| PIII | ▼ Sell | Other | 50,000 | — | 6/10/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
PIII appoints new Chief Clinical Officer
P3 Health Partners announced the appointment of a new Chief Clinical Officer. The executive will oversee clinical operations and strategy for the company. This addition brings additional expertise as the firm pursues its growth plans. The stock is currently trading with a low RSI and near its recent support level.
PIII appoints new Chief Clinical Officer. P3 Health Partners announced the appointment of a new Chief Clinical Officer. The executive will oversee clinical operations and strategy for the company. This addition brings additional expertise as the firm pursues its growth plans. The stock is currently trading with a low RSI and near its recent support level.